Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Terminated2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01814046Phase 2Terminated
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma
Metastatic Ocular MelanomaMetastatic Uveal Melanoma
PrincipalinvestigatorStart date: 2013-03-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Cancer Institute (NCI)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven Chmura, MD

University of Chicago

Related
5 trials

Shared therapeutic areas:

Melanoma
Similarity Score10%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Yoshiya Yamada, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Melanoma
Similarity Score10%

Deborah E Citrin, M.D.

National Cancer Institute (NCI)

Related
13 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Shakeel Modak, MD

Memorial Sloan Kettering Cancer Center

Related
10 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Glenn Lesser, MD

Wake Forest University Health Sciences

Related
10 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
16 trials

Shared therapeutic areas:

Melanoma
Similarity Score10%

William D Figg, Pharm.D.

National Cancer Institute (NCI)

Related
11 trials

Shared therapeutic areas:

Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01814046Phase 2PrincipalInvestigator

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

Metastatic Ocular MelanomaMetastatic Uveal Melanoma
Terminated
NCT00706992Phase 2PrincipalInvestigator

Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients

Melanoma
Terminated

All 2 trials loaded